Asahi Kasei Pharma Venture Capital
Overview
An evergreen strategic venture fund of Asahi Kasei Pharma Corporation that invests internationally in biopharmaceutical companies. It focuses on private, early-stage biotech, particularly on the development of innovative therapeutics and platforms in areas like immunology, inflammation, kidney disease, neurodegenerative disease, and rare diseases.
Portfolio Companies
1
Website
asahikasei-pharma.co.jpInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Azafaros | May 2025 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Asahi Kasei Pharma Venture Capital based?
Asahi Kasei Pharma Venture Capital is headquartered in Japan.
When was Asahi Kasei Pharma Venture Capital founded?
Founding year information for Asahi Kasei Pharma Venture Capital is not publicly available.
How many portfolio companies does Asahi Kasei Pharma Venture Capital have?
Asahi Kasei Pharma Venture Capital has 1 portfolio company in Caplight's dataset.
What are some companies in Asahi Kasei Pharma Venture Capital's portfolio?
Portfolio companies visible on Caplight include Azafaros.
What was Asahi Kasei Pharma Venture Capital's most recent investment shown here?
Asahi Kasei Pharma Venture Capital's most recent investment in this portfolio sample was in Azafaros in 2025.
What sectors does Asahi Kasei Pharma Venture Capital focus on?
Asahi Kasei Pharma Venture Capital focuses on Healthcare & Life Sciences.
What company stages does Asahi Kasei Pharma Venture Capital focus on?
Asahi Kasei Pharma Venture Capital typically invests at the Mid stage.